C81.2A
BillableMixed cellularity Hodgkin lymphoma, in remission
C81.2A is the ICD-10-CM code for Mixed cellularity Hodgkin lymphoma, in remission. It is a billable, specific code valid for reimbursement.
C00-D49 Neoplasms
Medications indicated for this condition
FDA labeling- MethylprednisoloneCorticosteroid [EPC]›
- Doxorubicin›
- CarmustineAlkylating Drug [EPC]›
- CyclophosphamideAlkylating Drug [EPC]›
- LomustineAlkylating Drug [EPC]›
- Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Sodium Chloride, Isopropyl Alcohol›
- Betamethasone Sodium Phosphate and Betamethasone Acetate, Bupivacaine Hydrochloride, Povidine Iodine›
- Bleomycin›
- Brentuximab VedotinCD30-directed Immunoconjugate [EPC]›
- ChlorambucilAlkylating Drug [EPC]›
- Cyclophosphamide for Injection›
- DacarbazineAlkylating Drug [EPC]›
Drugs whose FDA labeling lists this condition's category among its indications. Informational only — not a treatment recommendation or medical advice.
Conditions mapped to this code
MedlinePlus · NIHPlain-language health-topic references grounded in MedlinePlus (NIH/NLM).
Frequently asked questions
Source: CMS ICD-10-CM FY2026. For informational purposes only — not medical advice. See our medical disclaimer.
Look up another ICD-10 code or condition